[4-(5-ethanesulfonyl-pyridin-2-yloxy)-6-fluoro-1-methyl-naphthalen-2-yl]-acetic acid methyl ester | 1227385-17-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: [4-(5-ethanesulfonyl-pyridin-2-yloxy)-6-fluoro-1-methyl-naphthalen-2-yl]-acetic acid methyl ester
• 英文别名: methyl 2-[4-(5-ethylsulfonylpyridin-2-yl)oxy-6-fluoro-1-methylnaphthalen-2-yl]acetate
• CAS: 1227385-17-2
• 化学式: C₂₁H₂₀FNO₅S
• 分子量: 417.458
• InChiKey: NVHUAACYCBBETE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  29
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  90.9
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  (6-fluoro-4-hydroxy-1-methyl-naphthalen-2-yl)-acetic acid methyl ester 、 2-溴-5-(乙砜基)吡啶 、 2-(4-fluoro-benzylidene)-succinic acid 1-methyl ester 以[4-(5-ethanesulfonyl-pyridin-2-yloxy)-6-fluoro-1-methyl-naphthalen-2-yl]-acetic acid methyl ester (22.7 mg, 75%) was obtained as a light yellow solid的产率得到[4-(5-ethanesulfonyl-pyridin-2-yloxy)-6-fluoro-1-methyl-naphthalen-2-yl]-acetic acid methyl ester
  参考文献：
  名称：

  Naphthylacetic acids

  摘要：

  本发明涉及公式I的化合物及其药学上可接受的盐和酯，其中W、X、Y和R1-R7在详细说明和权利要求中有定义。此外，本发明还涉及制造和使用公式I的化合物的方法，以及包含这些化合物的药物组合物。公式I的化合物是CRTH2受体的拮抗剂或部分激动剂，可用于治疗与该受体相关的疾病和障碍，如哮喘。

  公开号：

  US08642629B2

文献信息

• NAPHTHYLACETIC ACIDS
  申请人：Chen Li

  公开号：US20100125058A1

  公开（公告）日：2010-05-20

  The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein W, X, Y, and R 1 -R 7 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds of formula I are antagonists or partial agonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.

  这项发明涉及公式I的化合物： 以及其药学上可接受的盐和酯，其中W、X、Y和R1-R7在详细说明和权利要求中有定义。此外，本发明涉及制造和使用公式I化合物的方法，以及含有这些化合物的药物组合物。公式I的化合物是CRTH2受体的拮抗剂或部分激动剂，可能在治疗与该受体相关的疾病和紊乱方面有用，如哮喘。
• US8642629B2
  申请人：——

  公开号：US8642629B2

  公开（公告）日：2014-02-04
• [EN] NAPHTHYLACETIC ACIDS<br/>[FR] ACIDES NAPHTYLACÉTIQUES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2010055004A1

  公开（公告）日：2010-05-20

  The invention is concerned with the compounds of formula I, and pharmaceutically acceptable salts and esters thereof, wherein W, X, Y, and R1- R7 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds of formula I are antagonists or partial agonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.